Key facts
- Notable investors include Dalton Venture.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Aiyisheng (Guangzhou) Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Aiyisheng (Guangzhou) Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aiyisheng (Guangzhou) Biotechnology
Developer of implantable medical devices designed to advance tissue repair and reconstruction. The company offers proprietary small-caliber artificial blood vessels with enhanced long-term patency and surgical adaptability, enabling healthcare providers to improve clinical outcomes for patients requiring vascular access and bypass procedures.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Aiyisheng (Guangzhou) Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aiyisheng (Guangzhou) Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aiyisheng (Guangzhou) Biotechnology in its N-PORT filings yet. We sweep new filings monthly.